A Doctors Take- Hi all. I've been following amrn for years. It amazes me how few really understand The importance of this trial. This drug has the capability of changing the cardiovascular space if it shows a reduction in mortality. The patients r baseline sicker and with more EPA than that in the Jelis study it should be a lock to show statistical significance (obviously anything can happen in a trial). With no side effects this really has shown so much promise. I have seen some posts about doctors being ignorant to drugs. Point taken because there are so many drugs we are bombarded with daily. . Doctos look for patient oriented outcomes. Aka yes they lower numbers in your blood and make ur lab work look great but does that translate to prolonging life or preventing heart attack or adverse event from happening. That's what we really care about.
I don't see an issue getting over 10 dollars with 10-20 well within reach with good results.
I am long amrn (heavily) and thus have a bias which I am disclosing. Any qs from a medical standpoint lmk. THX
Market Data 
Markets 
AI
